HCV Antiviral Drugs Have the Potential to Adversely Perturb the Fetal-Maternal Communication Axis through Inhibition of CYP3A7 DHEA-S Oxidation Article

Work, Hannah M, Hackett, John C, Lampe, Jed N. (2024). HCV Antiviral Drugs Have the Potential to Adversely Perturb the Fetal-Maternal Communication Axis through Inhibition of CYP3A7 DHEA-S Oxidation . 52(6), 516-525. 10.1124/dmd.123.001434

Open Access

cited authors

  • Work, Hannah M; Hackett, John C; Lampe, Jed N

sustainable development goals

authors

publication date

  • June 1, 2024

keywords

  • HEPATITIS-C VIRUS
  • INFECTION
  • Life Sciences & Biomedicine
  • PARITAPREVIR
  • PHARMACOKINETICS
  • PREGNANCY
  • Pharmacology & Pharmacy
  • RITONAVIR
  • Science & Technology
  • TRANSMISSION
  • WOMEN

Digital Object Identifier (DOI)

publisher

  • AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS

start page

  • 516

end page

  • 525

volume

  • 52

issue

  • 6